Zack focuses his practice on the representation of public and private pharmaceutical, biotechnology, and other life sciences companies with respect to a variety of intellectual property-based commercial transactions. He advises companies on license agreements, research collaborations and development agreements, manufacturing, distribution, and supply agreements, as well as intellectual property matters within corporate transactions such as public offerings and mergers and acquisitions. 

Download full bio 


  • Apollo Endosurgery to Be Acquired by Boston Scientific 

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Sixth Street Invests in Blueprint Medicines 


  • Duke University School of Law
    JD, Duke Estate Planning Council Scholarship (half-tuition), 2017

  • Washington University in Saint Louis
    BSBA, Finance
    Honors in Management, 2014

Admissions & Credentials

New York